| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.65B | — | +8.8% |
| Cost of Revenue | $845.3M | — | +10.2% |
| Gross Profit | $801.8M | — | +7.3% |
| R&D Expense | $134.6M | — | +4.3% |
| SG&A Expense | $117.3M | — | +8.8% |
| Operating Income | $398.2M | — | +11.3% |
| Interest Expense | $105.4M | — | +0.2% |
| Pre-tax Income | $303.1M | — | +16.0% |
| Income Tax | $76.8M | — | +59.7% |
| Net Income | $226.1M | — | +6.2% |
| EPS (Basic) | $0.94 | — | +8.0% |
| EPS (Diluted) | $0.91 | — | +8.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $420.9M | -8.9% | -18.3% |
| Accounts Receivable | $1.02B | +4.3% | +9.0% |
| Current Assets | $5.34B | -2.6% | -14.4% |
| Total Assets | $20.33B | -1.9% | -0.4% |
| Current Liabilities | $4.88B | -4.6% | -13.5% |
| Long-term Debt | $7.32B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $299.7M | — | +10.1% |
| Capital Expenditures | $6.0M | — | -52.8% |
| Investing Cash Flow | -$65.5M | — | -3.5% |
| Financing Cash Flow | -$741.1M | — | -179.2% |
| Free Cash Flow | $293.7M | — | +13.2% |
| +7.1% |
| Total Liabilities | $13.43B | -2.5% | -0.8% |
| Stockholders' Equity | $6.84B | -0.6% | +0.9% |